Aspire Capital Advisors’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Sell
5,652
-32,141
-85% -$2.58M 0.09% 89
2026
Q1
$2.86M Sell
37,793
-106,417
-74% -$8.31M 0.64% 31
2025
Q4
$10.8M Buy
144,210
+5,480
+4% +$409K 2.54% 11
2025
Q3
$10.2M Buy
138,730
+4,907
+4% +$352K 2.52% 12
2025
Q2
$9.47M Sell
133,823
-244
-0.2% -$16.3K 2.62% 11
2025
Q1
$8.54M Buy
134,067
+25,359
+23% +$1.59M 2.55% 14
2024
Q4
$6.36M Buy
108,708
+7,036
+7% +$439K 1.82% 16
2024
Q3
$6.71M Buy
101,672
+1,758
+2% +$113K 2% 15
2024
Q2
$6.25M Buy
99,914
+6,828
+7% +$427K 2.05% 15
2024
Q1
$5.83M Buy
+93,086
New +$5.57M 1.96% 15

Other funds holding JIRE

Aspire Capital Advisors's JIRE Position: Q2 2026 in Review

Aspire Capital Advisors reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 85% in Q2 2026, selling an estimated $2.58M and leaving 5,652 shares worth $466K. The position accounts for 0.09% of the portfolio, ranked #89.

Aspire Capital Advisors first reported a position in JIRE in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.8M in Q4 2025. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Aspire Capital Advisors held 5,652 shares of JPMorgan International Research Enhanced Equity ETF worth $466K as of Q2 2026.
  • Aspire Capital Advisors sold 32,141 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $2.58M.
  • JPMorgan International Research Enhanced Equity ETF made up 0.09% of Aspire Capital Advisors's portfolio in Q2 2026, its #89 holding.
  • Aspire Capital Advisors first reported a position in JPMorgan International Research Enhanced Equity ETF in Q1 2024 and has held it in 10 quarters since.
  • Aspire Capital Advisors's JPMorgan International Research Enhanced Equity ETF position peaked at $10.8M in Q4 2025.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Aspire Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.